Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Neoplasms of the CNS

  Free Subscription


1 Acta Neuropathol
1 BMC Cancer
1 Childs Nerv Syst
5 Clin Neuropathol
1 Int J Cancer
2 J Neurooncol
1 Nat Rev Neurol
3 Neuro Oncol
2 Neurology
1 Neuroradiology
1 Oncogene
1 PLoS One
2 Proc Natl Acad Sci U S A

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Acta Neuropathol

  1. VON BUEREN AO, Karremann M, Gielen GH, Benesch M, et al
    Correction to: A suggestion to introduce the diagnosis of "diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)".
    Acta Neuropathol. 2018 Aug 16. pii: 10.1007/s00401-018-1896.
    PubMed     Text format     Abstract available

    BMC Cancer

  2. JIAO XD, Ding C, Zang YS, Yu G, et al
    Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: a case report.
    BMC Cancer. 2018;18:206.
    PubMed     Text format     Abstract available

    Childs Nerv Syst

  3. CONTI A, Pontoriero A, Ghetti I, Senger C, et al
    Benefits of image-guided stereotactic hypofractionated radiation therapy as adjuvant treatment of craniopharyngiomas. A review.
    Childs Nerv Syst. 2018 Aug 27. pii: 10.1007/s00381-018-3954.
    PubMed     Text format     Abstract available

    Clin Neuropathol

  4. KEARNEY H, Cryan JB, Looby S, Brett FM, et al
    The DNA copy number landscape of a collision tumor.
    Clin Neuropathol. 2018;37:68-73.
    PubMed     Text format     Abstract available

  5. ALVAREZ R, Schild M, Cummings TJ
    Primary intracranial leiomyoma in an immunocompetent patient.
    Clin Neuropathol. 2018;37:85-86.
    PubMed     Text format    

  6. PRAYSON BE, Prayson RA
    Pituitary gland involvement by glioblastoma.
    Clin Neuropathol. 2018;37:42-44.
    PubMed     Text format    

  7. DAS S, Ang LC, Ramsay D
    Intrasellar cavernous hemangioma presenting as pituitary adenoma: A report of two cases and review of the literature.
    Clin Neuropathol. 2018;37:64-67.
    PubMed     Text format     Abstract available

  8. TAKEUCHI H, Neishi H, Higashino Y, Kitai R, et al
    Mitogen-activated protein kinase in gliosis and pilocytic astrocytoma.
    Clin Neuropathol. 2018;37:36-41.
    PubMed     Text format     Abstract available

    Int J Cancer

  9. OSTROM QT, Kinnersley B, Armstrong G, Rice T, et al
    Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age.
    Int J Cancer. 2018 Aug 27. doi: 10.1002/ijc.31759.
    PubMed     Text format     Abstract available

    J Neurooncol

  10. TAYLOR JW, Parikh M, Phillips JJ, James CD, et al
    Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma.
    J Neurooncol. 2018 Aug 27. pii: 10.1007/s11060-018-2977.
    PubMed     Text format     Abstract available

  11. DITMER A, Zhang B, Shujaat T, Pavlina A, et al
    Diagnostic accuracy of MRI texture analysis for grading gliomas.
    J Neurooncol. 2018 Aug 25. pii: 10.1007/s11060-018-2984.
    PubMed     Text format     Abstract available

    Nat Rev Neurol

  12. WOOD H
    Addition of bevacizumab fails to improve on temozolomide alone for glioma therapy.
    Nat Rev Neurol. 2018 Aug 29. pii: 10.1038/s41582-018-0067.
    PubMed     Text format    

    Neuro Oncol

  13. JACOBS DI, Fukumura K, Bainbridge MN, Armstrong GN, et al
    Elucidating the molecular pathogenesis of glioma: integrated germline and somatic profiling of a familial glioma case series.
    Neuro Oncol. 2018 Aug 24. pii: 5079134. doi: 10.1093.
    PubMed     Text format     Abstract available

  14. LIEBERMAN NAP, DeGolier K, Kovar HM, Davis A, et al
    Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: Implications for development of immunotherapy.
    Neuro Oncol. 2018 Aug 28. pii: 5085631. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. HENCH J, Bihl M, Bratic Hench I, Hoffmann P, et al
    Satisfying your neuro-oncologist: a fast approach to routine molecular glioma diagnostics.
    Neuro Oncol. 2018 Aug 30. pii: 5087930. doi: 10.1093.
    PubMed     Text format    


  16. TOYOTA T, Sennari Y, Okada K, Kawahara A, et al
    Myoclonia continua in primary CNS natural killer/T-cell lymphoma, nasal type.
    Neurology. 2016 Dec 7. pii: 10.1212/WNL.0000000000003515.
    PubMed     Text format    

  17. DUFFAU H
    Paradoxes of evidence-based medicine in lower-grade glioma: To treat the tumor or the patient?
    Neurology. 2018 Aug 29. pii: WNL.0000000000006288.
    PubMed     Text format     Abstract available


  18. SASAKI T, Kim J, Moritani T, Capizzano AA, et al
    Roles of the apparent diffusion coefficient and tumor volume in predicting tumor grade in patients with choroid plexus tumors.
    Neuroradiology. 2018;60:479-486.
    PubMed     Text format     Abstract available


  19. TAN Z, Song L, Wu W, Zhou Y, et al
    Correction: TRIM14 promotes chemoresistance in gliomas by activating Wnt/beta-catenin signaling via stabilizing Dvl2.
    Oncogene. 2018 Aug 29. pii: 10.1038/s41388-018-0467.
    PubMed     Text format     Abstract available

    PLoS One

  20. YUAN AL, Ricks CB, Bohm AK, Lun X, et al
    ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts.
    PLoS One. 2018;13:e0202860.
    PubMed     Text format     Abstract available

    Proc Natl Acad Sci U S A

  21. ARVANITIS CD, Askoxylakis V, Guo Y, Datta M, et al
    Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption.
    Proc Natl Acad Sci U S A. 2018 Aug 27. pii: 1807105115.
    PubMed     Text format     Abstract available

  22. MCBRAYER SK, Olenchock BA, DiNatale GJ, Shi DD, et al
    Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase.
    Proc Natl Acad Sci U S A. 2018;115:E3741-E3748.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.